Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells.
about
Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based TherapyStrategies to improve the immunosuppressive properties of human mesenchymal stem cellsConcise review: guidance in developing commercializable autologous/patient-specific cell therapy manufacturingPeriodontal ligament stem cells: current status, concerns, and future prospectsStem cell technology for bone regeneration: current status and potential applicationsImmunomodulatory Role of Mesenchymal Stem Cell Therapy in Vascularized Composite AllotransplantationStem Cells of Dental Origin: Current Research Trends and Key Milestones towards Clinical ApplicationMaking the Switch: Alternatives to Fetal Bovine Serum for Adipose-Derived Stromal Cell ExpansionProliferation and osteogenic differentiation of mesenchymal stem cells induced by a short isoform of NELL-1Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against StrokeGuided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarctionN-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible.Enhanced chondrogenesis of bone marrow-derived stem cells by using a combinatory cell therapy strategy with BMP-2/TGF-β1, hypoxia, and COL1A1/HtrA1 siRNAsMesenchymal stem cells as cellular vectors for pediatric neurological disordersEpigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation.Fibroblast growth factor-2 primes human mesenchymal stem cells for enhanced chondrogenesisBone tissue engineering with human stem cells.Adipose-derived mesenchymal stromal/stem cells: An update on their phenotype in vivo and in vitro.Fluorescence activated enrichment of CD146+ cells during expansion of human bone-marrow derived mesenchymal stromal cells augments proliferation and GAG/DNA content in chondrogenic media.Influence of FGF2 and PEG hydrogel matrix properties on hMSC viability and spreadingEvaluation of isolation methods and culture conditions for rat bone marrow mesenchymal stem cells.Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices.Isolation and characterization of two kinds of stem cells from the same human skin back sample with therapeutic potential in spinal cord injury.Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imagingImproved survival of mesenchymal stromal cell after hypoxia preconditioning: role of oxidative stress.Different culture media affect growth characteristics, surface marker distribution and chondrogenic differentiation of human bone marrow-derived mesenchymal stromal cells.Identification of appropriate reference genes for human mesenchymal cells during expansion and differentiation.Human adult stem cells maintain a constant phenotype profile irrespective of their origin, Basal media, and long term cultures.Selection of osteoprogenitors from the jaw periosteum by a specific animal-free culture mediumThe osteoblastogenesis potential of adipose mesenchymal stem cells in myeloma patients who had received intensive therapyClonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency.Multipotent mesenchymal stromal stem cell expansion by plating whole bone marrow at a low cellular density: a more advantageous method for clinical useCulture of human mesenchymal stem cells using a candidate pharmaceutical grade xeno-free cell culture supplement derived from industrial human plasma pools.Long-term results of adipose-derived stem cell therapy for the treatment of Crohn's fistula.Intra-renal delivery of mesenchymal stem cells attenuates myocardial injury after reversal of hypertension in porcine renovascular disease.Intrarenal Delivery of Mesenchymal Stem Cells and Endothelial Progenitor Cells Attenuates Hypertensive Cardiomyopathy in Experimental Renovascular Hypertension.Immortalisation with hTERT Impacts on Sulphated Glycosaminoglycan Secretion and Immunophenotype in a Variable and Cell Specific MannerBasic Fibroblast Growth Factor Stimulates the Proliferation of Bone Marrow Mesenchymal Stem Cells in Giant Panda (Ailuropoda melanoleuca).Transplanted Umbilical Cord Mesenchymal Stem Cells Modify the In Vivo Microenvironment Enhancing Angiogenesis and Leading to Bone Regeneration.Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity
P2860
Q26742060-0F7C171E-F4C8-4A6B-9F13-D71EB4697192Q26786626-85337F21-442D-4FB2-8573-0DEECC8470BEQ26825029-19161262-26B6-49AC-BC4D-2A4145575516Q26999471-5DDA0F50-F5E4-4808-A537-49BD7B05313BQ27015888-0864937D-68E0-44A4-AAB6-F185121822FDQ28067456-1CF4ECBE-69F6-4ECC-BD9C-E87EAA5B8A8EQ28073659-E2C4B431-C8E3-4325-91FE-1BBD05B0F340Q28079988-C9D3B271-5B4E-4DB0-B50B-5573175BFE97Q28648379-A35FD6E0-9D67-4C7E-932A-F4234719A295Q30370083-E4049E9F-453D-438C-895B-46D9029651BFQ30496413-DBB3FB27-8D91-490D-9C95-37ACC9D7250FQ33258763-8111F458-12C4-4F1F-B494-2F0048EF54ECQ33793961-D8E4E20A-1D58-4645-A3E3-47FD0B080249Q33918923-C21E2C6A-DEE2-4BFD-9968-1CAA6C254E24Q33939130-FEB802C2-8470-4D55-9049-CC6C1D96C149Q33983524-8DA3049B-6CFE-4BE7-BE78-D35DFAE217E7Q33999454-13AA2BD8-AD23-4EC7-87BB-D5600F1CDB7BQ34038832-73621023-3232-4D61-A412-C694CFEBA155Q34333995-E4AD9A32-6BFE-4526-9B00-981AEE76D0ECQ34346605-FA5903CE-8A0E-4D57-8B32-E7042EEFA6CFQ34421548-A0D04BEF-562B-40F8-93B6-10F481255B79Q34422955-DACBEF6F-2F7A-4B24-B110-8F359994B464Q34505175-00FF9AB4-6C72-4449-B752-6B49A374402FQ34618047-B0271A95-4509-4345-A375-16E22E676D5FQ34753654-533B9958-0F3B-48EA-B4A6-E31772D59070Q34881281-C10FCE14-26EC-4EBB-801E-AF064723A489Q34984540-8ECF95CB-D057-473F-BB2A-AFF988D0486DQ35061505-04FACF33-D5CA-4610-AB30-D31DEF52CF8CQ35069705-B6D14FBB-CE27-4F5A-BE3F-43C19A06A559Q35145061-2EFB110F-A171-4178-8609-AD9CEB2095F5Q35228246-001F06AB-6AED-4560-906B-163F25407A65Q35369603-11908BDE-0226-4995-8575-493EC560D26DQ35403742-BB9FB9B9-E0BE-4C7D-B807-768FF278A725Q35552089-80B26919-46A6-41F1-BD51-0FFA6428D6B6Q35562620-E2BAC089-39E4-4519-9B4E-8B19655257CFQ35634780-39B54F96-63CF-428A-AA8F-2AC8A84DE08AQ35702383-4405B3C8-A478-4080-A806-E7322D7751B2Q35777087-0717618E-0974-4A9A-896D-1C0571C230FAQ35844400-8F500338-A344-49DF-85ED-1D28D3753679Q35936886-D3C1DFDA-F644-4F8A-9EE9-A8C12F7A6CA0
P2860
Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Characterization of the optima ...... human mesenchymal stem cells.
@en
Characterization of the optima ...... human mesenchymal stem cells.
@nl
type
label
Characterization of the optima ...... human mesenchymal stem cells.
@en
Characterization of the optima ...... human mesenchymal stem cells.
@nl
prefLabel
Characterization of the optima ...... human mesenchymal stem cells.
@en
Characterization of the optima ...... human mesenchymal stem cells.
@nl
P2093
P1433
P1476
Characterization of the optima ...... human mesenchymal stem cells.
@en
P2093
Constantin N Baxevanis
Maria Salagianni
Michael Papamichail
Panagiota A Sotiropoulou
Sonia A Perez
P304
P356
10.1634/STEMCELLS.2004-0331
P577
2005-08-18T00:00:00Z